If it helps, Id appreciate you sharing the post
References & Research Leidy HJ et al
McGraw-Hill / Lange Rivera FB et al (2024): Cardiovascular and renal outcomes of glucagon-like peptide 1 receptor agonists among patients with and without type 2 diabetes mellitus: A meta-analysis of randomized placebo-controlled trials
With the matched group on semaglutide, 28 reported gastroparesis.[ref][ref] Diabetic retinopathy: Two clinical trials in people with diabetes linked GLP-1 RA drugs to an increased risk of diabetic retinopathy, while other studies show that the drugs were not associated with the eye disease
Planning for Special Occasions Holidays, travel, and special events require advance planning when managing Retatrutide and digestion
The cessation reflects the FDAs return to standard regulations, which limit compounding when approved drug versions are readily available